Dr. Robert Weisman is the director of the Head and Neck Oncology Program at the UC San Diego Moores Cancer Center, where he works with a skilled multidisciplinary team of specialists and sub-specialists to provide comprehensive diagnostic and therapeutic care to patients with cancers of the head and neck.
Dr. Weisman graduated from Washington University School of Medicine and completed his residency training in Head and Neck Surgery at UCLA. Prior to coming to UC San Diego, Dr. Weisman was an Associate Professor of Otolaryngology - Head and Neck Surgery at the University of Pennsylvania, and also spent four years in private practice in Rancho Mirage, California.
During his more than 25 years of practicing medicine, Dr. Weisman has had a number of clinical interests, most notably in head and neck oncology (cancers of the head and neck). He also has had a strong interest and extensive experience in plastic and reconstructive surgery of the head and neck, surgery of the orbit, trauma of the head and neck, and disorders of the thyroid and parathyroid glands.
Dr. Weisman teaches courses on an annual basis on surgery of the orbit (eye socket and adjacent structures) and surgery for cancers of the nose and sinuses, and has produced nationally-distributed videotapes on surgery of the salivary gland and reconstruction of the mandible. He is currently one of the leading members of the combined ENT-Endocrine Clinic at UC San Diego, where patients with thyroid and parathyroid disorders are evaluated and treated by a multidisciplinary team of specialists. Dr. Weisman frequently participates as an investigator in clinical trials of new treatments for head and neck cancer. He is one of only a few surgeons in San Diego who provides endoscopic laser treatment for cancer of the larynx.
He works with a skilled multidisciplinary team of specialists and sub-specialists to provide comprehensive diagnostic and therapeutic care to patients with cancers of the head and neck. UC San Diego is one of the few centers in the U.S. that offers patients with advanced head and neck cancer treatment with intra-arterial chemotherapy and concurrent radiation therapy (RADPLAT). This approach was pioneered at UC San Diego, and produces cure rates for Stage IV disease that are greater than expected based on experience with other approaches.